Integrated Pharmaceutical Medicine Stipend Funding
Policy Number: 3349-21-50
Effective Date: 08/29/2016
Responsible Department:Integrated Pharmaceutical Medicine
Approval Authority: Dean, College of Graduate Studies
The purpose of this Policy is to establish the stipend funding source(s) for Integrated Pharmaceutical Medicine (IPM) students.
This Policy applies to any IPM students who receive a stipend, as well as any faculty who appoint IPM students in their research lab.
C. Policy Statement
- Students enrolled in the College of Graduate Studies IPM program that receive a stipend will be funded through the IPM program budget during the completion of their didactic coursework or the first two (2) years in the program (whichever occurs first).
- Upon completion of didactic coursework or two (2) years in the program (whichever occurs first) and selection of a research lab, student stipends will be funded in part by the research lab. The research lab will be expected to fund half of the stipend for the duration of the time the student is in the lab, with an expected timeframe of one (1) to three (3) years. This timeline of a total of five (5) years of funding is in compliance with the College of Graduate School Academic Program Length Policy (https://www.neomed.edu/graduatestudies/academics/policies-forms/)
- New faculty pre-funding are allowed to request to have one (1) student in their lab without funding their stipend; however, new faculty should propose a plan to support student research. In addition, if faculty receive funding that can support a student during the course of a student’s participation in their lab, the faculty member will be required to begin providing funding to the student.
- If a Faculty member loses funding during the course of a student’s research in their lab, the IPM program will subsidize the remaining stipend payment.